SOLV Scorecard | SOLVENTUM CORPORATION

40 QUARTERS × 3 ROAST BATTLES

4/120 0.2 / 5 stars All 120 Win/Lose results shown below

SOLV Roast Me summary

Solventum Corp (SOLV). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.

Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 25 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q21/3	LoseSOLV / S&P SOLV unavailable / 15.20%	LoseSOLV / S&P -0.93% / 15.00%	WinSOLV / S&P 276.50% / 50.40%
2026-Q11/3	LoseSOLV / S&P SOLV unavailable / -4.33%	LoseSOLV / S&P -0.55% / 11.30%	WinSOLV / S&P 275.58% / 27.70%
2025-Q41/3	LoseSOLV / S&P SOLV unavailable / 2.65%	LoseSOLV / S&P 0.86% / 9.00%	WinSOLV / S&P 221.74% / 13.40%
2025-Q31/3	LoseSOLV / S&P SOLV unavailable / 8.12%	LoseSOLV / S&P 2.28% / 4.61%	WinSOLV / S&P 109.40% / 13.45%
2025-Q20/3	LoseSOLV / S&P SOLV unavailable / 10.94%	LoseSOLV / S&P 2.21% / 4.83%	LoseSOLV / S&P -64.48% / 10.63%
2025-Q10/3	LoseSOLV / S&P SOLV unavailable / -4.27%	LoseSOLV / S&P 1.29% / 4.98%	LoseSOLV / S&P -70.91% / 10.57%
2024-Q40/3	LoseSOLV / S&P SOLV unavailable / 2.41%	LoseSOLV / S&P 0.70% / 5.25%	LoseSOLV / S&P -64.57% / 6.15%
2024-Q30/3	LoseSOLV / S&P SOLV unavailable / 5.89%	LoseSOLV / S&P SOLV unavailable / 5.89%	LoseSOLV / S&P SOLV unavailable / 6.11%
2024-Q20/3	LoseSOLV / S&P SOLV unavailable / 4.28%	LoseSOLV / S&P SOLV unavailable / 5.38%	LoseSOLV / S&P SOLV unavailable / 5.12%
2024-Q10/3	LoseSOLV / S&P SOLV unavailable / 10.56%	LoseSOLV / S&P SOLV unavailable / 5.71%	LoseSOLV / S&P SOLV unavailable / 5.59%
2023-Q40/3	LoseSOLV / S&P SOLV unavailable / 11.69%	LoseSOLV / S&P 0.82% / 6.81%	LoseSOLV / S&P 0.13% / 7.78%
2023-Q30/3	LoseSOLV / S&P SOLV unavailable / -3.27%	LoseSOLV / S&P SOLV unavailable / 7.52%	LoseSOLV / S&P SOLV unavailable / -5.03%
2023-Q20/3	LoseSOLV / S&P SOLV unavailable / 8.74%	LoseSOLV / S&P SOLV unavailable / 9.50%	LoseSOLV / S&P SOLV unavailable / -8.57%
2023-Q10/3	LoseSOLV / S&P SOLV unavailable / 7.50%	LoseSOLV / S&P SOLV unavailable / 10.77%	LoseSOLV / S&P SOLV unavailable / -15.69%
2022-Q40/3	LoseSOLV / S&P SOLV unavailable / 7.56%	LoseSOLV / S&P SOLV unavailable / 11.88%	LoseSOLV / S&P SOLV unavailable / -17.99%
2022-Q30/3	LoseSOLV / S&P SOLV unavailable / -4.88%	LoseSOLV / S&P SOLV unavailable / 13.47%	LoseSOLV / S&P SOLV unavailable / -1.41%
2022-Q20/3	LoseSOLV / S&P SOLV unavailable / -16.10%	LoseSOLV / S&P SOLV unavailable / 13.71%	LoseSOLV / S&P SOLV unavailable / 11.04%
2022-Q10/3	LoseSOLV / S&P SOLV unavailable / -4.60%	LoseSOLV / S&P SOLV unavailable / 15.97%	LoseSOLV / S&P SOLV unavailable / 42.23%
2021-Q40/3	LoseSOLV / S&P SOLV unavailable / 11.03%	LoseSOLV / S&P SOLV unavailable / 15.00%	LoseSOLV / S&P SOLV unavailable / 96.40%
2021-Q30/3	LoseSOLV / S&P SOLV unavailable / 0.58%	LoseSOLV / S&P SOLV unavailable / 10.77%	LoseSOLV / S&P SOLV unavailable / 69.42%
2021-Q20/3	LoseSOLV / S&P SOLV unavailable / 8.55%	LoseSOLV / S&P SOLV unavailable / 6.58%	LoseSOLV / S&P SOLV unavailable / 51.81%
2021-Q10/3	LoseSOLV / S&P SOLV unavailable / 6.17%	LoseSOLV / S&P SOLV unavailable / -1.06%	LoseSOLV / S&P SOLV unavailable / 7.39%
2020-Q40/3	LoseSOLV / S&P SOLV unavailable / 12.15%	LoseSOLV / S&P SOLV unavailable / -3.72%	LoseSOLV / S&P SOLV unavailable / -33.42%
2020-Q30/3	LoseSOLV / S&P SOLV unavailable / 8.93%	LoseSOLV / S&P SOLV unavailable / -2.04%	LoseSOLV / S&P SOLV unavailable / -27.10%
2020-Q20/3	LoseSOLV / S&P SOLV unavailable / 20.54%	LoseSOLV / S&P SOLV unavailable / -0.46%	LoseSOLV / S&P SOLV unavailable / -27.11%
2020-Q10/3	LoseSOLV / S&P SOLV unavailable / -19.60%	LoseSOLV / S&P SOLV unavailable / 3.47%	LoseSOLV / S&P SOLV unavailable / -14.75%
2019-Q40/3	LoseSOLV / S&P SOLV unavailable / 9.07%	LoseSOLV / S&P SOLV unavailable / 5.36%	LoseSOLV / S&P SOLV unavailable / 2.99%
2019-Q30/3	LoseSOLV / S&P SOLV unavailable / 1.70%	LoseSOLV / S&P SOLV unavailable / 5.02%	LoseSOLV / S&P SOLV unavailable / 0.21%
2019-Q20/3	LoseSOLV / S&P SOLV unavailable / 4.30%	LoseSOLV / S&P SOLV unavailable / 6.64%	LoseSOLV / S&P SOLV unavailable / 8.65%
2019-Q10/3	LoseSOLV / S&P SOLV unavailable / 13.65%	LoseSOLV / S&P SOLV unavailable / 8.12%	LoseSOLV / S&P SOLV unavailable / 14.29%
2018-Q40/3	LoseSOLV / S&P SOLV unavailable / -13.52%	LoseSOLV / S&P SOLV unavailable / 9.05%	LoseSOLV / S&P SOLV unavailable / 18.23%
2018-Q30/3	LoseSOLV / S&P SOLV unavailable / 7.71%	LoseSOLV / S&P SOLV unavailable / 10.21%	LoseSOLV / S&P SOLV unavailable / 19.06%
2018-Q20/3	LoseSOLV / S&P SOLV unavailable / 3.43%	LoseSOLV / S&P SOLV unavailable / 9.03%	LoseSOLV / S&P SOLV unavailable / 14.46%
2018-Q10/3	LoseSOLV / S&P SOLV unavailable / -0.76%	LoseSOLV / S&P SOLV unavailable / 7.68%	LoseSOLV / S&P SOLV unavailable / 12.46%
2017-Q40/3	LoseSOLV / S&P SOLV unavailable / 6.64%	LoseSOLV / S&P SOLV unavailable / 7.03%	LoseSOLV / S&P SOLV unavailable / 13.82%
2017-Q30/3	LoseSOLV / S&P SOLV unavailable / 4.48%	LoseSOLV / S&P SOLV unavailable / 5.68%	LoseSOLV / S&P SOLV unavailable / 17.57%
2017-Q20/3	LoseSOLV / S&P SOLV unavailable / 3.09%	LoseSOLV / S&P SOLV unavailable / 4.83%	LoseSOLV / S&P SOLV unavailable / 17.74%
2017-Q10/3	LoseSOLV / S&P SOLV unavailable / 6.07%	LoseSOLV / S&P SOLV unavailable / 3.67%	LoseSOLV / S&P SOLV unavailable / 13.32%
2016-Q40/3	LoseSOLV / S&P SOLV unavailable / 3.82%	LoseSOLV / S&P SOLV unavailable / 2.09%	LoseSOLV / S&P SOLV unavailable / 7.05%
2016-Q30/3	LoseSOLV / S&P SOLV unavailable / 3.85%	LoseSOLV / S&P SOLV unavailable / 0.20%	LoseSOLV / S&P SOLV unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-25.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Penumbra Inc (PEN)	United States	$12.596B	77.33
BAXTER INTERNATIONAL INC (BAX)	United States	$12.139B	-10.35
GLOBUS MEDICAL INC (GMED)	United States	$9.977B	20.03
INSULET CORP (PODD)	United States	$9.420B	28.12
GLAUKOS Corp (GKOS)	United States	$9.135B	-43.73
MiniMed Group, Inc. (MMED)	United States	$5.748B	-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)	United States	$5.212B	28.44
TELEFLEX INC (TFX)	United States	$5.093B	-5.44
HAEMONETICS CORP (HAE)	United States	$4.821B	36.52
Heartflow, Inc. (HTFL)	United States	$4.225B